ライフサイエンスコーパス: infant mortality

1 sociation between air pollution exposure and infant mortality.

2 iginal hypothesis about OPV0 increasing male infant mortality.

3 ngenital anomalies are the leading causes of infant mortality.

4 ational age, Apgar scores, preterm birth, or infant mortality.

5 MA) is the most frequent cause of hereditary infant mortality.

6 sease that is the leading heritable cause of infant mortality.

7 a non-significant increase in perinatal and infant mortality.

8 th (OPV0) was associated with increased male infant mortality.

9 everity and the most common genetic cause of infant mortality.

10 cillus Calmette-Guerin (BCG) reduces overall infant mortality.

11 s, with a reversal of this trend at very low infant mortality.

12 e association between maternal education and infant mortality.

13 y result in increased maternal morbidity and infant mortality.

14 hereby decreasing the burden of maternal and infant mortality.

15 e SMN1 gene, is the leading genetic cause of infant mortality.

16 did not reduce all-cause maternal, fetal, or infant mortality.

17 ar atrophy (SMA), a leading genetic cause of infant mortality.

18 omalies are a leading cause of perinatal and infant mortality.

19 trophy (SMA) is the leading genetic cause of infant mortality.

20 and weakening the force of selection against infant mortality.

21 f low birth weight may have little effect on infant mortality.

22 gregation plays an independent role in black infant mortality.

23 hy (SMA) is the most common genetic cause of infant mortality.

24 workers is highly significant in explaining infant mortality.

25 disease that is the leading genetic cause of infant mortality.

26 ted forms of neurological disease leading to infant mortality.

27 tcomes but is not on the "causal" pathway to infant mortality.

28 e first 6 mo of life is critical to reducing infant mortality.

29 ate overall effects of prenatal variables on infant mortality.

30 and birth weight, and for the prevention of infant mortality.

31 Prematurity is one of the leading causes of infant mortality.

32 humans and the most common genetic cause of infant mortality.

33 trophy (SMA) is the leading genetic cause of infant mortality.

34 ygen saturation homozygote, because of lower infant mortality.

35 ronutrient supplementation on fetal loss and infant mortality.

36 failed to reduce overall fetal loss or early infant mortality.

37 term births, which is a major contributor to infant mortality.

38 infertility, and reduce maternal, fetal, and infant mortality.

39 etween the preceding interbirth interval and infant mortality.

40 It is the most common genetic cause of infant mortality.

41 s and their odds ratios for transmission and infant mortality.

42 e were significant independent predictors of infant mortality.

43 ere iodine deficiency decreases neonatal and infant mortality.

44 s infection continues to be a major cause of infant mortality.

45 ation of the irrigation water would decrease infant mortality.

46 prenatal magnesium sulfate exposure on VLBW infant mortality.

47 us (HIV) type 1 contributes significantly to infant mortality.

48 y of these findings and measure reduction in infant mortality.

49 BW percentiles were determined to predict infant mortality.

50 icial non-specific effects (NSE) in reducing infant mortality.

51 ated with a higher rate of fetal or neonatal/infant mortality.

52 ostneonatal mortality, or specific causes of infant mortality.

53 r disease, is the leading monogenic cause of infant mortality.

54 ntaneous preterm birth is a leading cause of infant mortality.

55 iated with increased risks of stillbirth and infant mortality.

56 virus (RSV) bronchiolitis causes significant infant mortality.

57 ring pregnancy and lifetime and postneonatal infant mortality.

58 lifetime exposure to PM2.5 increases risk of infant mortality.

59 discharge explained the racial disparity in infant mortality.

60 ain the benefits of paid maternity leave for infant mortality.

61 obesity are risk factors for stillbirth and infant mortality.

62 birth defects and are a significant cause of infant mortality.

63 .96) for stillbirth and 1.29 (1.00-1.67) for infant mortality.

64 ar atrophy, the leading genetic disorder for infant mortality.

65 e compared with inequalities in postneonatal infant mortality (28 days to 1 year), which is not relat

66 ons were associated with a high incidence of infant mortality (30.9%, 95% CI 2.4 to 5.4) and fetal wa

67 income, and key health indicators including infant mortality (43.0 vs 16.0 per 1000 nationwide) and

68 Infant mortality accounted for 48.1% of all mortality re

69 g cause of long-term neurologic handicap and infant mortality, accounting for 35% of all infant death

70 is one of the most common genetic causes of infant mortality across different races and is caused by

71 e prices, cigarette price differentials, and infant mortality across the European Union.

72 ween prenatal magnesium sulfate exposure and infant mortality (adjusted rate ratio, 1.02; 95% confide

73 The reduction in male excess infant mortality after 1970 can be attributed to improve

74 Infant mortality after invasive MRSA and MSSA infections

75 f stillbirth and neonatal, postneonatal, and infant mortality after the second pregnancy.

76 Infant mortality also differed significantly between the

77 ratively few studies evaluated particles and infant mortality, although infants and children are part

78 , the authors studied pregnancy outcomes and infant mortality among 202 married women in West Bengal,

79 l load, pregnancy outcomes, and maternal and infant mortality among 913 HIV-infected pregnant women.

80 opulations since Israel was founded in 1948, infant mortality among Arabs is still more than twice as

81 nded an intervention programme to reduce the infant mortality among Bedouin Arabs.

82 heart defects (CHD) are the leading cause of infant mortality among birth defects, and later morbidit

83 RSV was also a leading cause of infant mortality among study participants.

84 ial virus (RSV) is a global leading cause of infant mortality and adult morbidity.

85 Congenital anomalies are a leading cause of infant mortality and are important contributors to subse

86 design by estimating the association between infant mortality and birth weight in several regions of

87 ion (CVM), and it remains a leading cause of infant mortality and childhood morbidity.

88 rse consequences including increased risk of infant mortality and chronic health conditions.

89 2015 to examine levels of and disparities in infant mortality and deaths of despair in the 19 US CDs

90 Because of the increased infant mortality and developmental outcome associated wi

91 ortant implications for our understanding of infant mortality and fertility in past societies(1).

92 er than increased use, contributed to reduce infant mortality and improved long-term health as proxie

93 found clear evidence for increased rates of infant mortality and increased homozygosity of putativel

94 trophy (SMA) is the leading genetic cause of infant mortality and is caused by the loss of a function

95 atrophy is the most common genetic cause of infant mortality and is characterized by degeneration of

96 ry effect on the selected health indicators, infant mortality and life expectancy at birth.

97 rimarily birth weight) is a key predictor of infant mortality and morbidity and may serve as a predic

98 eptococcus (GBS) is a leading cause of young infant mortality and morbidity globally, with vaccines b

99 erm birth (PTB) contributes significantly to infant mortality and morbidity with lifelong impact.

100 Low birth weight is an important cause of infant mortality and morbidity worldwide.

101 UGR) still accounts for a large incidence of infant mortality and morbidity worldwide.

102 eterm delivery (PTD) is the leading cause of infant mortality and morbidity worldwide.

103 Preterm birth (PTB), a leading cause of infant mortality and morbidity, has a complex etiology w

104 a coli (EPEC) is responsible for significant infant mortality and morbidity, particularly in developi

105 ewborn (PPHN) is associated with substantial infant mortality and morbidity.

106 ment did not alleviate child malnutrition or infant mortality and negligibly influenced multidimensio

107 hich has been associated with disparities in infant mortality and other chronic conditions.

108 ina and India, the only countries where both infant mortality and overall under-five mortality were e

109 children were limited to prevented cases of infant mortality and respiratory illnesses, with a monet

110 mes, including abortion, maternal mortality, infant mortality, and birth defects; leukemia; and Reye

111 ch as life expectancy at birth and child and infant mortality, and have shown some contradictory resu

112 utcome known to be associated with increased infant mortality, and it often results in a higher burde

113 e prevalences of HIV, tuberculosis, malaria, infant mortality, and maternal mortality.

114 modium falciparum is a major cause of global infant mortality, and no effective vaccine currently exi

115 increased rates of post-neonatal mortality, infant mortality, and under-5 mortality rates.

116 he variation in rates of maternal mortality, infant mortality, and under-five mortality across countr

117 Reductions in infant mortality associated with increases in the durati

118 We estimated the neonatal and infant mortality associated with these two characteristi

119 albendazole rose by 59 g (95% CI 19-98), and infant mortality at 6 months fell by 41% (RR 0.59; 95% C

120 Cumulative infant mortality at 7 months was significantly higher fo

121 Controlling for low birth weight, infant mortality, average income (socioeconomic status),

122 ight distribution has little or no effect on infant mortality, because the birth-weight-specific mort

123 it is the most frequently inherited cause of infant mortality, being the result of mutations in the s

124 genetic defects that lead to pregnancy loss, infant mortality, birth defects, and genetic diseases in

125 , we propose potential avenues to reduce the infant mortality burden at high altitudes and reduce pul

126 lly residents incurred the penalty of higher infant mortality, but as mortality rates fell at the end

127 mentation with 52 micromol vitamin A reduced infant mortality by 64%; acute side effects were limited

128 y how onshore oil spills affect neonatal and infant mortality by combining spatial data from the Nige

129 erweight/obesity and risks of stillbirth and infant mortality by including both population and sister

130 ue to differential changes in cause-specific infant mortality by sex.

131 tibiotic-naive infants' gut microbiomes, and infant mortality caused by resistant infections is high.

132 MN supplements had an 18% reduction in early infant mortality compared with those of women given IFA

133 idence rate ratios (IRRs) for stillbirth and infant mortality, comparing exposed births to unexposed

134 ity, we carried out a study by analyzing the infant mortality data from the Shenyang Women and Childr

135 The primary outcome was early infant mortality (deaths until 90 days post partum).

136 he autonomous region during the same period, infant mortality declined from 64 to 59 per 1000 and und

137 sis of 15 developed countries shows that, as infant mortality declined over two centuries, the excess

138 listings increased 27 PP, and blood group O infant mortality decreased 13 PP (P < 0.01).

139 ife expectancy improved from 48 to 69 years, infant mortality decreased from 76 deaths per 1000 liveb

140 ht, in this case maternal age, can influence infant mortality directly but not indirectly through bir

141 istribution and 2) maternal age also affects infant mortality directly, but 3) the influence of mater

142 ath data (2000-2010) to evaluate the risk of infant mortality due to external causes in multiples ver

143 ted controlled direct effect of plurality on infant mortality due to external causes was 1.64 (95% CI

144 gher-order multiples were at greater risk of infant mortality due to external causes, particularly be

145 ransition, with a reduction in childhood and infant mortality due to improved public health measures,

146 gnancy is associated with increased risks of infant mortality due to NEC in preterm babies, especiall

147 y associations of air pollution exposure and infant mortality during the different trimesters of preg

148 ationship between low maternal education and infant mortality, especially for neonatal mortality.

149 eight are associated with high perinatal and infant mortality, especially in developing countries.

150 tion, as compared with IFA, can reduce early infant mortality, especially in undernourished and anaem

151 SMSXI was associated with a reduction in infant mortality from conditions covered by the programm

152 Declines in infant mortality from infections and the shift of deaths

153 weaning, abrogating the benefit of reducing infant mortality from malaria.

154 ect (CDE) of maternal education on offspring infant mortality, further split into neonatal (0-27 days

155 A leading cause of infant mortality globally, its resurgence in several dev

156 imple preventive and therapeutic modalities, infant mortality has almost been abolished in high-incom

157 In conclusion, infant mortality has been continuously decreased in Shen

158 Although infant mortality has improved in all subpopulations sinc

159 Preterm birth, a major determinant of infant mortality, has been increasing in recent years.

160 No other cases of infant mortality have been observed at this site in 30 y

161 Socioeconomic disparities in infant mortality have persisted for decades in high-inco

162 We investigated the effect of OPV0 on infant mortality in a randomized trial in Guinea-Bissau.

163 tment and maternal anaemia, birthweight, and infant mortality in a study of prenatal supplements, in

164 important factor in the national decrease in infant mortality in China.

165 xamined the impact on birth weight and early infant mortality in comparison with controls, who receiv

166 Preterm birth is the leading cause of infant mortality in developed countries, but the associa

167 ficant human pathogen and a leading cause of infant mortality in developing countries.

168 a significant cause of diarrheal disease and infant mortality in developing countries.

169 bsiella pneumoniae is an increasing cause of infant mortality in developing countries.

170 ading cause of severe intestinal disease and infant mortality in developing countries.

171 lobal significance and a major cause of high infant mortality in endemic nations.

172 Low birth weight (LBW) infants have lower infant mortality in groups in which LBW is most frequent

173 tating early-life interventions and reducing infant mortality in LMICs and warrant further discussion

174 tenatal vaccination could potentially reduce infant mortality in LMICs, broader gains at the populati

175 whether paid maternity leave policies affect infant mortality in LMICs.

176 pplements on stillbirth, birth outcomes, and infant mortality in low-income and middle-income countri

177 her efforts are still needed to decrease the infant mortality in rural areas.

178 Risks of infant mortality in second pregnancy only increased with

179 dium falciparum contributes significantly to infant mortality in sub-Saharan Africa and is associated

180 ant determinant of vertical transmission and infant mortality in subtype C infection in Zimbabwe.

181 ome (SIDS)-the leading postneonatal cause of infant mortality in the developed world.

182 The leading cause of infant mortality in the developing world is infectious d

183 ce differentials were associated with higher infant mortality in the European Union.

184 was associated with a 49% reduction in early infant mortality in the first 6 mo of life (RR: 0.51; 95

185 pregnancies affects risks of stillbirth and infant mortality in the second-born offspring.

186 anti-RSV Ab prophylaxis has greatly reduced infant mortality in the United States, there is currentl

187 ow-birth-weight infants, preterm births, and infant mortality in the United States.

188 ital heart defects remain a leading cause of infant mortality in the western world, despite decades o

189 a prevalent cause of traveler's diarrhea and infant mortality in third-world countries.

190 iated with increased risks of stillbirth and infant mortality independently of genetic and early envi

191 Infant mortality is 89.4/1000, and 12% of children die b

192 The strong association of birth weight with infant mortality is complicated by a paradoxical finding

193 red by kin after an infant death, so evolved infant mortality is lower.

194 Thus, evolved infant mortality is relatively high, more so in larger k

195 The leading genetic cause of infant mortality is spinal muscular atrophy (SMA), a cli

196 However, the US national policy for reducing infant mortality is to reduce low birth weight.

197 ike African elephants in zoos, this species' infant mortality is very high (for example, twice that s

198 besity and increased risks of stillbirth and infant mortality is well documented, but it has often be

199 rophy (SMA), the leading genetic disorder of infant mortality, is caused by low levels of survival mo

200 atrophy (SMA), the leading genetic cause of infant mortality, is caused by the loss of the survival

201 ron disease and the leading genetic cause of infant mortality; it results from loss-of-function mutat

202 mothers have a higher risk of NEC-associated infant mortality [light smoking: adjusted odds ratio (aO

203 me (SIDS), the leading cause of postneonatal infant mortality, likely comprises heterogeneous disorde

204 US Census were used in the denominator; for infant mortality, live birth counts were used.

205 ed for population, life expectancy at birth, infant mortality, low and high birthweight, maternal mor

206 Infant mortality, low birthweight, and placental malaria

207 The maternal cumulative prevalence of infant mortality (mIM), the maternal cumulative prevalen

208 Preterm birth is a leading cause of infant mortality, morbidity, and long-term disability, a

209 t effective means of preventing maternal and infant mortality/morbidity; however, influenza vaccinati

210 is, age-adjusted mortality (all causes), and infant mortality; more low-birth-weight infants; and hig

211 and functional outcomes such as neonatal and infant mortality; motor, cognitive, and emotional develo

212 risk of stillbirth or neonatal, 6-month, or infant mortality, neither overall or in any of the 26 ex

213 c mice survived probiotic colonization, some infant mortality occurred in beige-athymic pups born to

214 3-27 weeks of gestation) was associated with infant mortality (odds ratio, 288.1; 95% CI, 271.7-305.5

215 0 g/L) at enrolment had a reduction in early infant mortality of 25% (RR 0.75, 0.62-0.90, p=0.0021) a

216 Small babies from a population with higher infant mortality often have better survival than small b

217 n (OR = 1.01, 95% CI: 0.38, 2.70) or overall infant mortality (OR = 1.33, 95% CI: 0.43, 4.04).

218 female literacy (P = .01), as well as lower infant mortality (P = .007); however, no differences in

219 mortality rates for suicides (p < 0.001) and infant mortality (p = 0.003) increased during the crisis

220 and a 2.1-fold increase (95% CI, 1.3-3.5) in infant mortality (P<.01).

221 (400/mm3) were significantly associated with infant mortality (P=.035, Fisher's exact test).

222 h are, in turn, associated with neonatal and infant mortality, particularly in low- and middle-income

223 New Zealand), I found that the sex ratio of infant mortality peaked in the 1970s or 1980s and declin

224 There was no significant difference in infant mortality (pooled RR, 0.98 [95% CI, 0.29-3.26]; 6

225 Outcomes were rates of all-cause infant mortality, postneonatal mortality, and external c

226 atrophy (SMA), the leading genetic cause of infant mortality, predominantly affects high metabolic t

227 quality was strongly associated with greater infant mortality (r=0.69, p=0.004 for women; r=0.74, p=0

228 ) was associated with a 4.6% decrease in the infant mortality rate (aIRR, 0.95; 95% CI, 0.91-0.99).

229 5M can follow distinct trajectories from the infant mortality rate (IMR) and under 5 mortality rate (

230 rence greater than 1 year in 15 populations; infant mortality rate for 18 of 19 populations with a ra

231 The twin infant mortality rate for women with intensive prenatal

232 The very high infant mortality rate indicates a substantial need for r

233 The infant mortality rate is 38 per 1000 live births, with d

234 rtality rate is 54 per 1000 live births, the infant mortality rate is 46 per 1000 live births, and th

235 The early invitation with MMS group had an infant mortality rate of 16.8 per 1000 live births vs 44

236 e less likely to give birth and had a higher infant mortality rate than uninfected females.

237 Infant mortality rate was most strongly associated with

238 t in accounting for maternal mortality rate, infant mortality rate, and under-five mortality rate (wi

239 ssion analyses with maternal mortality rate, infant mortality rate, and under-five mortality rate as

240 nce of spontaneous abortions and the highest infant mortality rate.

241 prenatal care utilization also have a lower infant mortality rate.

242 996 and remained lower than the overall twin infant mortality rate.

243 tion were maternal, perinatal, neonatal, and infant mortality rates (MMR, PMR, NMR, and IMR, respecti

244 To compare the pattern of cause of death of infant mortality rates by urban/rural areas as well as t

245 ic situation, Albania has one of the highest infant mortality rates in Europe (45.4 per 1000 live bir

246 Maternity leave reduces neonatal and infant mortality rates in high-income countries.

247 ors do not fully explain the persistent high infant mortality rates of African Americans (blacks).

248 ntal factors associated with improvements in infant mortality rates over the last century explain the

249 o independent effect of segregation on black infant mortality rates was found.

250 in the early part of the 20th century, when infant mortality rates were high.

251 between prenatal smoking and NEC-associated infant mortality rates with adjustment for potential con

252 ated over areas of the country with elevated infant mortality rates, an indicator of institutional ef

253 ias, voting behavior, prior low birth weight/infant mortality rates, and demographic characteristics.

254 However, in countries with high infant mortality rates, low parity women had an increase

255 vidence, including the fact that, unlike for infant mortality rates, maternal mortality rates tended

256 Infant mortality rates, percent change, and annual perce

257 W) neonates (<2500 g at inclusion) to reduce infant mortality rates, we observed a very beneficial ef

258 vironmental circumstances, as indexed by low infant mortality rates, were relatively advantageous for

259 tion plays an independent role in high black infant mortality rates.

260 f young mothers, even during periods of high infant mortality rates.

261 Annual infant mortality rates.

262 Infant-mortality rates decreased in the treated areas of

263 Setting the parameters (e.g. infant mortality, reduction of interbirth interval, life

264 er, disparities persisted; overall and among infants, mortality resulting from CHD was consistently h

265 xis was non-inferior to IPTp with respect to infant mortality (risk difference [RD] -0.05, 95% CI -0.

266 Infant mortality rose from 47 per 1000 live births durin

267 Primary outcomes were neonatal and infant mortality, self-reported morbidity (health status

268 The infant mortality significantly decreased by 5.92%, 7.41%

269 en and young people aged 1-24 years, with UK infant mortality similar to the EU15+ median.

270 score at 5 min and the risk of neonatal and infant mortality, subdivided by specific causes.

271 to smokers had higher risks of both LBW and infant mortality than infants born to nonsmokers.

272 ed rates of spontaneous abortion and overall infant mortality that have been reported in some studies

273 micronutrients did not significantly reduce infant mortality; there were 764 deaths (54.0 per 1000 l

274 The primary outcome was all-cause infant mortality through 6 months (180 days).

275 women related to pregnancy, stillbirth, and infant mortality to 12 weeks (84 days) following pregnan

276 cid supplementation did not reduce all-cause infant mortality to age 6 months but resulted in a non-s

277 hy (SMA) is the most common genetic cause of infant mortality, typically resulting in death preceding

278 is the leading cause of hospitalization and infant mortality under six months of age worldwide; ther

279 The male disadvantage in infant mortality underwent a surprising rise and fall in

280 rends in preterm birth rates on neonatal and infant mortality was also evaluated.

281 However, among LBW infants, infant mortality was lower for infants born to smokers (

282 Overall 1-year 5% infant mortality was similar to the 2%-4% post-neonatal

283 in Mali-a poorly resourced country with high infant mortality-was technically and logistically feasib

284 The MRRs between maternal education and infant mortality were 1.63 (95% CI 1.48-1.80, P < 0.001)

285 carotene groups the rates of stillbirth and infant mortality were 47.9 (95% CI, 44.3-51.5), 45.6 (95

286 bortion, stillbirth, neonatal mortality, and infant mortality were estimated with logistic regression

287 vertical transmission of subtype C HIV, and infant mortality were examined in 251 HIV-seropositive w

288 OR 0.77), while inequalities in postneonatal infant mortality were more than double that in absolute

289 However, the risk of stillbirth and infant mortality when accounting for previous maternal p

290 nowledge gained about the black/white gap in infant mortality when national birth and infant death re

291 e women (BMI >/=30) had an increased risk of infant mortality when population controls were used (OR

292 th increasing sex ratios, except at very low infant mortality, where sex ratios decreased with total

293 igarette prices were associated with reduced infant mortality, while increased cigarette price differ

294 s were the most common identifiable cause of infant mortality, with 47 genetic diseases identified in

295 al tube closure defects are a major cause of infant mortality, with exencephaly accounting for nearly

296 ) remains an important cause of maternal and infant mortality worldwide, including countries with mod

297 g causes of premature birth and maternal and infant mortality worldwide, preeclampsia remains a major

298 syncytial virus (RSV) is a leading cause of infant mortality worldwide.

299 weakness and is the leading genetic cause of infant mortality worldwide.

300 iated with hypoketotic hypoglycemia and high infant mortality yet occurs at high frequency in Canadia